THU0083 the Relevance of Elevated CRP as an Inclusion Criterion in Clinical Trials in Patients With Rheumatoid Arthritis

doi 10.1136/annrheumdis-2017-eular.2316
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Genetic Markers and Clinical Relevance in Rheumatoid Arthritis

International Journal of Rheumatic Diseases
Rheumatology
2015English

Patients With Rheumatoid Arthritis in Clinical Care

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Canadian Recommendations for Clinical Trials of Pharmacologic Interventions in Rheumatoid Arthritis: Inclusion Criteria and Study Design

Journal of Rheumatology
RheumatologyAllergyImmunology
2011English

Melatonin as an Adjuvant Therapy in Patients With Rheumatoid Arthritis

British Journal of Clinical Pharmacology
Pharmacology
2008English

AB0340 Clinical Efficacy of Statins in Patients With Rheumatoid Arthritis

2017English

Drug Trials in Rheumatoid Arthritis

InPharma
1980English

NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Microchimerism in the Rheumatoid Nodules of Patients With Rheumatoid Arthritis

Arthritis & Rheumatism
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy